AstraZeneca's rheumatoid arthritis pill fostamatinib failed to meet one of the end goals of a late-stage clinical trial, raising doubt in the pill and the drug company's ability to revamp its battered pipeline.
http://www.foxbusiness.com/industries/2013/04/05/astrazenecas-arthritis-pill-fails-to-meet-one-end-goal-in-late-stage-trial/
http://www.foxbusiness.com/industries/2013/04/05/astrazenecas-arthritis-pill-fails-to-meet-one-end-goal-in-late-stage-trial/
No comments:
Post a Comment